W 274 (Lamotrigine extended-release 50 mg)
Pill imprint W 274 has been identified as Lamotrigine extended-release 50 mg.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; anxiety; borderline personality disorder (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 50 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- W 274
- Strength:
- 50 mg
- Color:
- Pink
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Wockhardt USA LLC
- National Drug Code (NDC):
- 64679-0274
- Inactive Ingredients:
- diethyl phthalate
ferric oxide red
hypromelloses
lactose monohydrate
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
magnesium silicate
titanium dioxide
More about lamotrigine
Consumer resources
- Lamotrigine
- Lamotrigine chewable dispersible tablets
- Lamotrigine extended-release tablets
- Lamotrigine orally disintegrating tablets
- Lamotrigine (Advanced Reading)
- Other brands: Lamictal, Lamictal XR, Lamictal ODT, Lamictal CD
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
